EDGE PharmaTech financials
A multi-period view of the public annual-account figures reported for EDGE PharmaTech, with comparable measures and links to available source documents.
Company overviewRegistry number
0753817088
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for EDGE PharmaTech
2025 versus 2024
- Operating line
- €82,190
- EBITDA
- €81,961
- Total assets
- €96,045
- Equity
- €7,813
+66.5%
+66.2%
+19.4%
+56.3%
EBITDA margin +99.7% · Equity ratio +8.1%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.